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Highlights 
 110 whole blood samples were analysed for 12 age-correlated CpGs using the Illumina MiSeq 
 17 different statistical models were developed using R and Trajan Neural Network Simulation 
 A support vector machine model was selected with a MAE of 4.1 years in the blind test set 
 The accuracy of both DNA methylation quantification and age prediction was retained down to 
2ng of DNA input in the PCR stage 
 Saliva samples (n=34) were accurately predicted with an error of less than 4 years for 50% of the 
samples and less than 7 years for 70%. 
 No variation in DNA methylation was detected for sperm samples 
 
 
 
 
Abstract 
 
The field of DNA intelligence focuses on retrieving information from DNA evidence that can help 
narrow down large groups of suspects or define target groups of interest. With recent breakthroughs 
on the estimation of geographical ancestry and physical appearance, the estimation of chronological 
age comes to complete this circle of information. Recent studies have identified methylation sites in 
the human genome that correlate strongly with age and can be used for the development of age-
estimation algorithms. In this study, 110 whole blood samples from individuals aged 11-93 years were 
analysed using a DNA methylation quantification assay based on bisulphite conversion and massively 
parallel sequencing (Illumina MiSeq) of 12 CpG sites. Using this data, 17 different statistical modelling 
approaches were compared based on root mean square error (RMSE) and a Support Vector Machine 
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with polynomial function (SVMp) model was selected for further testing. For the selected model 
(RMSE= 4.9 years) the mean average error (MAE) of the blind test (n=33) was calculated at 4.1 years, 
with 52% of the samples predicting with less than 4 years of error and 86% with less than 7 years. 
Furthermore, the sensitivity of the method was assessed both in terms of methylation quantification 
accuracy and prediction accuracy in the first validation of this kind. The described method retained its 
accuracy down to 10 ng of initial DNA input or ~2ng bisulphite PCR input. Finally, 34 saliva samples 
were analysed and following basic normalisation, the chronological age of the donors was predicted 
with less than 4 years of error for 50% of the samples and with less than 7 years of error for 70%.  
Keywords: DNA methylation; age prediction; artificial neural networks; machine learning; whole 
blood; saliva; sperm 
 
Introduction 
 
In a forensic era where intelligence information regarding an individual’s physical appearance can be 
retrieved from DNA material [1-3], the accurate determination of chronological age from crime scene 
samples has the potential to significantly aid forensic investigations towards identifying and finding 
unknown individuals. In the majority of the forensic cases where intact skeletal remains are available, 
age determination can be conducted successfully by anthropological measurements and calculations 
as well as cross-referencing with medical records. In the quest of identifying the perpetrator of a 
crime, however, it is highly unlikely for the biological evidence to consist of something other than body 
fluids, shed hairs and/or fingerprints. In those scenarios, especially when any direct comparisons with 
DNA and/or fingerprint databases are unable to provide a definitive match, the need for an age 
prediction method based on biological material emerges. 
Over recent years, several approaches employing biomarkers for age prediction have been 
investigated. Extensive research has focused on the correlation of age and telomere length [3-9], while 
biomarkers including the quantification of a 4977bp deletion in the mitochondrial genome [10-12], 
measurement of aspartic acid racemisation [13-15], detection of somatic gene rearrangement in T-
cells via its products (sjTRECs) [16], measurement of advanced glycation end product accumulation 
(AGEs) [17] and, finally, analysis of mRNA profiles [18] have also been investigated over the years. 
However, several restrictions including significant effects of variables other than age [9, 19-25], lack 
of precision and reproducibility [26, 27], as well as restrictions in age range [18, 25, 28] and tissue 
applicability [27, 29] are overshadowing the proposed age prediction methods. 
Differentiation in gene expression governs to a significant extent most physiological processes, 
including ageing. As epigenetic factors are known for their key role in modulating gene expression, it 
comes as no surprise that current research on age estimation has navigated heavily towards this area 
[30-32]. Epigenetic factors comprise of post-translational histone modifications, nucleosomal 
remodelling, chromatin looping, certain non-coding RNAs and DNA methylation. 
DNA methylation is a chemical modification that primarily affects cytosines when these are followed 
by guanines in a 5’-3’ direction in the DNA double helix and, in mammalian cells, results in the addition 
of a methyl group (-CH3) to their 5’ carbon (C5). These 5’-3’ CG methylation sites in the DNA are called 
‘CpG’ dinucleotides and are mostly methylated in the human genome (70-80%) [33]. The 
unmethylated CpGs are predominantly encountered in groups of high CG density known as ‘CpG 
islands’ most commonly located at the 5’ end of the regulatory region of genes [34]. Their position 
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around the regulatory region of genes, as well as the fact that approximately 60% of human genes 
[34] can be linked to specific CpG islands, suggests methylation’s key role in modulating gene 
expression [31]. Although a general tendency for hypo-methylation with age has been observed in the 
human genome [35-37], recent studies have brought to light evidence suggesting that methylation 
can also occur de novo in regions related to key developmental genes [38-40], highlighting a role in 
the physiological process of human ageing.  
Since the first evidence of correlation between human ageing and DNA methylation, a significant 
amount of research has been conducted in this direction. A methylation-based age prediction method 
incorporating data from various CpG sites was proposed as early as 2010 by Teschendorff et al. in their 
study [40], followed by Horvath’s epigenetic ‘ageing clock’ formed by 353 age-correlated CpG sites in 
2013 [41]. Furthermore, in addition to models using large numbers of methylation sites, a number of 
age estimation models have been successfully developed based on less than 10 CpG sites [30, 42, 43] 
suggesting the high potential of DNA methylation in age determination. 
Recent studies on DNA methylation have also identified a number of characteristics that highlight the 
potential of this approach for forensic applications where the number of unknown variables in regard 
to the DNA source increases drastically. The majority of studies on DNA methylation and age 
correlation have failed to identify any sex-specific bias for age-related CpG sites [37, 42, 44-47], while 
a recent study suggests that ethnicity can also be excluded as a factor of bias [48]. Furthermore studies 
have shown no significant changes in the methylation status when comparing samples of living and 
deceased individuals [45, 49] or fresh and long stored samples [43, 46, 50-52] suggesting a high 
stability for DNA methylation that can contribute significantly to the robustness of a DNA methylation 
based assay. 
On the other hand, there are points raised by the literature that require further investigation if a 
method is to be applied in forensics. While a number of studies have been able to identify CpG sites 
exhibiting similar correlation with age between two or more distinct tissues [31, 39-41, 49, 53, 54], 
several studies report tissue specificity of their age-related CpG sites and subsequent failure to 
reproduce predictions in multiple tissues [32, 41, 46, 55-60]. These results suggest that differential 
methylation with age might be similar or significantly different between different tissues depending 
on the specific CpG site and, therefore, when designing an age-prediction model for forensic 
applications the multi-tissue applicability of the method should be investigated thoroughly. 
Furthermore, it is possible that the ideal DNA methylation-based age estimation tool that would be 
applicable to all tissues might not be a feasible target and tissue specific models should be designed 
instead. A second issue highlighted by current research is that of the effect of various health and 
environmental factors on the methylation status of age related CpG sites [32, 41, 61-64] which 
introduces a new parameter that needs to be investigated when validating an age prediction model 
based on DNA methylation. Finally, two other important factors to consider when designing a method 
for application in forensics is target size and sensitivity, as DNA evidence recovered from crime scenes 
is often of poor quality and low quantity. Methods based on amplicons over 300bp long [43, 44], or 
DNA material requirements higher than 100ng [30, 44, 46, 49, 53] might not be applicable to degraded 
DNA samples. A limited number of reports have been recently published using more forensically 
relevant quantities of bisulphite-converted DNA in the PCR stage. In their studies, Naue et al. as well 
as Zbieć-Piekarksa et al. have reportedly achieved high prediction accuracy using as little as 10ng in 
the PCR stage [43, 65], while similar studies have reported promising results using 20ng of DNA in the 
same stage [45, 66].  
The quantification of DNA methylation for age estimation is currently conducted with four main 
methods: (i) pyrosequencing, (ii) the EpiTYPER system based on MALDI-TOF mass spectrometry, (iii) 
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methylation SNaPshot and (iv) massively parallel sequencing (MPS). Although all these techniques 
have been successfully applied in age estimation, massively parallel sequencing appears to be the best 
candidate for forensic applications as it is characterised by high sensitivity, single base resolution and 
large multiplexing capabilities. Furthermore, the MPS technology has been successfully applied to 
multiple aspects of forensic analysis [67-71] and DNA methylation-based age prediction methods have 
been recently attempted on the MPS platform providing promising preliminary results, with one 
method reporting a mean average deviation (MAD) of 4.4 years between the true and the predicted 
age of the donors using 16 markers [72] and a second reporting a MAD of 3.2 years using both 13 or a 
sub-selection of 4 markers [65]. 
Finally, when it comes to correlating DNA methylation data and age in a prediction model, a variety of 
different statistical approaches have been adopted by the various research groups. Most prediction 
models so far have been developed using linear univariate [43, 46, 48, 53] or multivariate least-squares 
regression analysis [30, 44, 64]. However, the success of recent machine learning approaches [65, 72, 
73] has begun to raise doubts on the ability of linear models to truly grasp the complexity of the 
relationship between the DNA methylation state and human ageing [44, 49, 61]. However, even with 
recent publications focusing on models applying complicated algorithms [65, 72, 73], there has been 
no detailed comparison, to this day, on the efficiency and complementarity of the different modelling 
approaches when it comes to methylation-based age prediction.   
The aim of this study is to systematically optimise all the parameters of a methylation-based age 
estimation assay in order to make this type of analysis realistic in a forensic scenario. From assessing 
the robustness of the method through reproducibility experiments, to selecting the optimal statistical 
approach for the predictive modelling and investigating into parameters such as sensitivity and multi-
tissue applicability, this study attempts to break down a 12 CpG assay based on the marker selection 
by Vidaki et al. in 2017 [72] and place it under the forensic microscope.  
Materials and Methods 
 
Sample Collection 
This study operated under ethical approval granted by the Biomedical Sciences, Dentistry, Medicine 
and Natural & Mathematical Sciences Research Ethics Subcommittee (BDM/13/14-30) in regards to 
sample collection from various tissues for DNA methylation analysis. Whole blood samples were 
collected from a total of 110 unrelated donors aged 11 to 92.9 years through venepuncture. 
Additionally, 34 saliva samples and 11 semen samples were collected from unrelated donors aged 
between 16-90.5 and 23-50 respectively by deposition in 15mL universal receptacles. Full informed 
consent regarding the analysis was acquired prior to sampling from the donors or their parents or 
legal guardians for the cases of under-aged individuals. Samples were stored at 4oC. All semen donors 
are also part of the saliva sample set, while blood donors originated from a different group of 
participants. All samples were unconnected to any disease study, and information was not collected 
regarding medical history of the donors in the effort to create an inclusive, unbiased dataset that 
would be representative of the general population.  
DNA Standards of known methylation 
In order to assess the sensitivity of the method two pre-mixed methylation standards (EpigenDx, 
Massachusetts, USA) corresponding to 5% and 25% methylation were used in inputs of 50, 25, 10 and 
1ng. 
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DNA Extraction and Quantification  
Genomic DNA extractions were carried out using a BioRobot®EZ1 automated purification instrument 
(Qiagen, Hilden, Germany) in combination with the EZ1 Blood kit for whole blood samples and the EZ1 
DNA Investigator kit for all other samples. For semen samples, differential extraction was performed 
in combination with the BioRobot®EZ1 and EZ1 DNA Investigator kit, in order to separate the sperm 
and epithelial fractions and only the sperm fraction was analysed further. Samples were subsequently 
stored at -20°C. Quantification of DNA extracts was conducted using the Quantifiler® Trio DNA 
Quantification kit in combination with the ABI PRISM® 7500 Sequence Detection System, both 
provided by Thermo-Fisher Scientific (Massachusetts, USA). The manufacturer’s guidelines [74] were 
followed throughout the protocol in half volumes and all samples were quantified in duplicates.  
Sodium Bisulphite Conversion 
Treatment with sodium bisulphite was employed for the conversion of unmethylated cytosines to 
uracils in the DNA samples. A total of 50ng of DNA from each sample or calibration standard was 
treated using the MethylEdge® Bisulphite Conversion System (Promega Corporation, Wisconsin USA) 
and the converted DNA was eluted in 10µL of the elution buffer provided. Eluates were stored at 4°C 
for up to a week and at -20°C up to one month according to the manufacturer’s guidelines [75]. The 
approximate recovery of DNA following bisulphite conversion using this chemistry has been calculated 
as 52% [76] and therefore the final concentration of the eluate is estimated at approximately 2.6ng/µL. 
Age-associated CpG sites 
This study is based on 12 out of the 16 CpG sites previously described by Vidaki et al. [72] in 2017. 
Removal of the remaining 4 markers was deemed necessary due to their poor amplification efficiency 
and low overall contribution to the prediction accuracy. Information on the location and gene 
association of the CpGs is displayed in Table 1. Primers used in this study are of the same design as 
those originally described by Vidaki et al. [72] with the exception of cg17274064 for which primers 
were redesigned to improve the amplification efficiency (Forward primer sequence: 
GGGAGGGAATAAGTATTTTTTTAA, Reverse primer sequence: ACAACTAAAATAACTCCACTTTC). 
Table 1. Chromosomal location and genetic information on the 12 CpG sites employed in this study. 
Marker CpG Chromosomal location Gene 
1 cg04084157 7: 100,809,049 VGF – nerve growth factor inducible precursor 
2 cg02085507 19: 6,739,192 TRIP10 – thyroid hormone receptor interactor 10 
3 cg04528819 7: 130,418,315 KLF14 – Kruppel-like factor 14 
4 cg19761273 17: 80,232,096 CSNK1D – casein kinase 1; delta isoform 1 
5 cg20692569 7: 72,848,481 FZD9 – frizzled 9 
6 cg27544190 21: 33,785,434 C21orf63 – chromosome 21 open reading frame 63 
7 cg01511567 11: 57,103,631 SSRP1 – structure specific recognition protein 1 
8 cg22736354 6: 18,122,719 NHLRC1 – malin  
9 cg17274064 21: 40,033,892 ERG – v-etseryhtroblastosis virus E26 oncogene like isoform 2 
10 cg07158339 9: 71,650,237 FXN – frataxin, mitochondrial isoform 1 preproprotein  
11 cg05442902 22: 21,369,010 P2RXL1 – purinergic receptor P2X-like 1; orphan receptor 
12 cg06493994 6: 25,652,602 SCGN – secretagogin precursor 
 
Amplification of the bisulphite-converted DNA 
Amplification of DNA following bisulphite treatment was performed using two multiplex reactions, the 
first containing primers for the amplification of amplicons 1-7 (Table 1) and the second targeting 
amplicons 8-12 (Table 1). The Qiagen Multiplex PCR kit was used for both reactions in half volume 
(25µL). Each reaction comprised of 12.5µL of 2x Qiagen Multiplex PCR Master Mix (providing a 
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concentration of 3mM MgCl2), an additional 1µL of 25mM MgCl2 solution for a final concentration of 
4mM, 2µL (~5ng) of bisulphite treated DNA or calibration standard and 9.5µL of primer mix. The final 
concentration of primers in the two multiplex reactions ranged from 0.2 to 0.5µM depending on the 
efficiency of the primers (Table 2).  The reaction conditions were: (1) 95°C for 15min, (2) 32 cycles 
consisting of 94°C for 30s, Tm (see Table 2) for 30s and 72°C for 30s, (3) 72°C for 4min followed by a 
hold at 4°C (Table 2).  
 
Table 2. Details of the multiplex reactions employed in this study.  
Marker CpG Primer concentration in 
multiplex PCR (µM) 
Annealing temperature 
1 cg04084157 0.3  
 
 
50°C for the first 7 cycles and 48°C for the next 25 cycles 
2 cg02085507 0.4 
3 cg04528819 0.3 
4 cg19761273 0.5 
5 cg20692569 0.5 
6 cg27544190 0.4 
7 cg01511567 0.2 
8 cg22736354 0.3  
 
52°C 
9 cg17274064 0.4 
10 cg07158339 0.4 
11 cg05442902 0.3 
12 cg06493994 0.2 
 
Post-PCR Purification and Quantification 
 
Following amplification, samples were purified using the MinElute® PCR Purification kit by Qiagen in 
order to remove unincorporated primer residues [77]. Elution was performed in 11µL PCR-grade 
water. Prior to library preparation all samples were quantified using the Qubit® dsDNA HS Assay kit 
(Thermo Fisher Scientific) according to the manufacturer’s guidelines [78] and in combination with the 
Qubit 2.0 Fluorometer instrument and clear thin-walled 0.5mL PCR tubes. 
 
Library Preparation and Quantification 
 
The preparation of sequencing libraries was performed with the Kapa Hyper Prep® kit for Illumina 
(Roche, Basel, Switzerland) starting with 50ng of purified PCR product per sample. Library preparation 
was performed according to the manufacturer’s specifications [79] in half volumes. For the size 
selection stages, AMPure® XP Beads (Beckman Coulter Genomics, California USA) and Illumina 
Resuspension Buffer were used (Illumina, California USA). Finally, library amplification was performed 
for 8 cycles.  
 
Quantification of the libraries was conducted with the KAPA Library Quantification Kit for Illumina 
platforms (Roche) [80]. Libraries were diluted 1:4000 in PCR-grade water prior to quantification and 
analysed in duplicate. Following quantification, DNA libraries were normalised to 20nM using Tris-HCL 
10mM/ pH 8.5 with 0.1% Tween (EBT buffer) and were pooled together in equal amounts to a final 
volume of 240µL (24 samples per run). Following denaturation and dilution to 10pM, 500µL of library 
was mixed with 100µL of denatured 20pM PhiX control (Illumina) and loaded in the MiSeqFGx 
instrument (Illumina) using the MiSeq version 2 cartridge and reagents. 
 
 
Sequencing 
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Sequencing of the libraries was performed using the Illumina MiSeqFGx benchtop instrument 
(Illumina). Sample sheets and sample plates were created in the Illumina Experiment Manager 
software and the instrument was set to perform paired-end sequencing of 151bp in each direction 
while the analysis workflow was set to ‘FASTQ only’. The online platform Basespace® (Illumina) was 
used for monitoring the performance of the runs as well as retrieve the sequencing files.  
 
Data Analysis and Normalisation 
 
Analysis of the FASTQ files was conducted with the Burrows-Wheeler Aligner (BWA) [81], Sequence 
Alignment/Map (SAMtools) [82], and Genome Analysis Toolkit (GATK, Broad Institute, Massachussets 
USA) [83] software. Sequences were aligned to a custom genome where all non-CpG cytosines were 
replaced by thymines. For CpG positions information was collected for the presence of both cytosines 
and thymines. Files were extracted in variant call format (VCF) using the R® Project for Statistical 
Computing software in combination with R Studio® platform and were subsequently processed with 
Microsoft Office Excel software. The methylation percentage (ß-values) for the 12 targeted CpGs was 
calculated by comparing the number of cytosine reads (suggesting the presence of methylation) to 
the combined total of cytosine and thymine (suggesting the absence of methylation) reads at each 
locus. A similar analysis was carried out for all non-CpG cytosine sites in each locus in order to establish 
the conversion efficiency of the bisulphite treatment. Non-CpG cytosines are expected to be free of 
methylation [84, 85] and therefore should be converted to uracils and subsequently to thymines 
following bisulphite treatment and amplification. Any cytosines therefore detected in those positions 
are indicative of incomplete conversion and the methylation percentages for the relevant CpGs were 
corrected accordingly. Average methylation values between duplicates was calculated based on the 
number of sequencing reads for each duplicate and each marker, where the methylation value of the 
duplicate with the higher number of sequencing reads contributed accordingly high to the final 
methylation score for the relevant marker following the equation:  
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 𝑣𝑎𝑙𝑢𝑒 𝑓𝑜𝑟 𝐶𝑝𝐺𝑖
= (𝐶𝑝𝐺𝑖 𝑀𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 𝑉𝑎𝑙𝑢𝑒 𝑎) ∗ (
(𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑎)
𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑎 + 𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑏
)
+ (𝐶𝑝𝐺𝑖 𝑀𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 𝑉𝑎𝑙𝑢𝑒 𝑏) ∗ (
𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑏
𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑎 + 𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑏
)   
 
Where CpGi corresponds to a specific marker and a and b correspond to the two replicates of the 
specific sample. Prior to statistical analysis and modelling methylation ß-values were converted to M-
values following the equation: 
𝑀𝑖 = 𝑙𝑜𝑔2(
ß𝑖
1 − ß𝑖
) 
where Mi represents the M-value for a certain marker in a specific sample and ßi represents the 
equivalent ß-value, and were normalised by centring around the median value for the dataset. 
Datasets corresponding to different tissues were normalised separately. 
 
Age Prediction  
For model fitting, the whole blood dataset was randomly split into training (70%, n=76) and validation 
(i.e., blind) subsets (30%, n=33). Using the training dataset, different software was then used to assess 
different kinds of models. 
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The Trajan® Neural Network Simulation package (Trajan Software Ltd., Durham UK) was employed in 
order to perform generalised regression neural network modelling (GRNN), an artificial neural 
network modelling approach that uses radial basis and linear functions together to rapidly learn from 
existing knowledge and produce a prediction output (i.e. age), and provide a direct comparison to 
previously reported results [72]. Parameter tuning was performed by holdout cross-validation using 
an internal verification subset composed by 10 out the 76 samples used for training. During each 
training round the software was set to develop 106 networks and display the best 50. Those networks 
were subsequently assessed on the degree and consistency in prediction accuracy across the training 
and verification subsets and the best networks were put through a new round of training until the 
point when no further improvement was observed.  
Additionally, R project for statistical computing software version 3.3.3 in combination with the caret 
package [86] was employed in order to test fourteen regression methods: ordinary linear (LM), partial 
least squares (PLS), ridge regression (Ridge), elastic net (Enet), lasso regression (LASSO), bagging 
multivariate adaptive regression splines (BagMARS), k nearest neighbours (KNN), extreme learning 
machines (ELM), single-layer feedforward perceptron neural network using a single hidden layer 
(NNet.SLP) and two hidden layers (NNET.2MLP), support vector machines with radial (SVMr) and 
polynomial function (SVMp) as kernels, random forest exploiting classification trees algorithms as base 
learners (RFclass) and boosted trees (BT). Parameter tuning was performed by leave-one-out cross-
validation.  
All models were finally validated using the validation (blind) subset. Both the GRNN networks and R 
models were trained and blind tested using the same sample subsets. 
Statistical analysis 
The comparison of the different models was based on root-mean-square error (RMSE). Mean absolute 
error and median absolute error values were also used for the purpose of comparison with previous 
studies. In order to assess the similarity of the developed statistical models, residuals for the different 
samples were compared between the models using analysis of variance (ANOVA) and paired t-test 
with Bonferroni post-hoc correction. Additionally, a general classification and regression tree model, 
pruning on error, was employed to group the different models based on similarity of the residuals. 
The attempt to combine the different approaches was carried out by selecting the best performing 
model of each group (based on RMSE) and averaging the predicted ages between those models. 
Results and Discussion 
Reproducibility assessment 
The first step in assessing the validity of this method was to establish its reproducibility in terms of the 
quantification of DNA methylation. In order to investigate this, 110 blood samples were put through 
the process in duplicate starting from the bisulphite conversion stage. The average absolute difference 
in methylation between duplicates was calculated to be less than 3% for all markers (Fig.1). Taking 
into account the range in DNA methylation observed in the 12 markers used in this study (between 
20-40%) a maximum of 3% average difference in methylation quantification between replicates was 
considered a satisfactory result. 
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Figure 1. Average absolute difference between duplicates (n=110) for the 12 different markers. The error bars 
represent the standard error. 
 
Development of an age prediction model using Generalised Neural Networks 
In the prediction model described by Vidaki et al. the mean absolute prediction error (MAE) 
calculated during the development of the model using publicly available methylation data increased 
from 3.3 to 7.1 years of age when the model was applied to data collected in-house via an MPS 
method even after normalisation had been applied [72]. Variation in the technical aspects of a DNA 
methylation quantification method has been shown to affect the final methylation values obtained 
and, thus, would be expected to affect prediction accuracy between different datasets [42]. For this 
reason, this increase in the prediction error was believed to occur partly due to variations in the 
processing of samples as well as the sequencing techniques between the BeadChip array 
methodology, used to generate the data included in the publicly available datasets, and the 
forensically orientated method developed in this study. In order to investigate the magnitude of this 
platform-based effect, the age prediction model was retrained using the same statistical modelling 
approach but restricting the training dataset to data solely generated with the developed MPS 
method. Blood samples from 110 individuals of known age were analysed in duplicate and the results 
were subsequently used to train (66 samples), validate (10 samples) and blind test (33 samples) a 
generalised regression neural network for age prediction using the same software as the previous 
publication [72]. The distribution of different ages in the dataset is shown in Figure 2.  
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Figure 2. Distribution of blood samples used in the model between the different age groups in the training 
(orange, n=66), validation (yellow, n=10) and test set (green, n=33). 
The mean absolute prediction error of the model was calculated at 0.8 years of age for the training 
set (n=66), 2.8 years of age for the validation set (n=10) and at 4.7 years for the external blind test 
set (n=33) (Fig.3) placing the developed model amongst the most accurate ones using a limited 
number of markers published to this day [30, 44, 47, 65]. This prediction error is very similar to the 
expected mean absolute prediction error calculated in the BeadChip array training data of the original 
model (3.3 years) [72], suggesting that the previous loss of accuracy was indeed a result of inter-
method variability. Furthermore, the high similarity in the accuracy of the two models is impressive 
given the fact that the model developed in this study was trained with approximately 13 times fewer 
samples than the original model developed by Vidaki et al. [72]. However, this apparently high 
performance is perhaps offset somewhat when comparing the training and verification set prediction 
accuracies to that of the external blind test set accuracy. It was apparent that this artificial neural 
network approach may have suffered from shortcomings with generalisability using fewer training 
cases (e.g. over-training, etc.).  
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Figure 3. Comparison between the predicted and the true age for the training (blue, n=66), validation 
(orange, n=10) and blind test set (red, n=33). The mean absolute prediction error was calculated at 0.8, 2.8 
and 4.7 years respectively.  
Evaluating the efficiency of different modelling approaches 
While statistical modelling using generalised regression neural networks (GRNN) generated an age 
prediction model with a relatively low mean absolute prediction error and root square mean error 
(RMSE=5.8 years), several factors, including its susceptibility to overfitting and loss of generalizability 
when the training dataset is small (n<1000), suggested that this modelling approach is less than ideal 
for this set of data. A GRNN ensemble model consisting of 6 individual GRNNs was also developed in 
an attempt to further stabilize the algorithm and increase its ability to generalize but the prediction 
error obtained in the blind test set for this model was very similar to that of the single GRNN 
(RMSE=6.1 years, MAE=4.9 years). In order to determine the optimal approach, 15 additional 
statistical models were trained using an identical training subset. While MAE is the most popular 
statistics for reporting prediction errors in this type of application, RMSE is a more appropriate 
statistic for comparing the performance of different prediction algorithms developed on the same 
dataset and thus it was chosen for this study. Based on this comparison and while linear models did 
not outperform the GRNN model, several non-linear approaches showed increased accuracy, with 
the support vector machine with polynomial function (SVMp) giving an RMSE of 4.9 years (MAE=4.1 
years) in the validation subset (Fig.4).  AC
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Figure 4. Combined graph of the residuals (grey) and RMSEs (red) for the blind test set (n=33) for the 
different statistical models. 
Comparison of the individual sample residuals between models (i.e. the difference between the 
actual and predicted age for each sample, with every model) revealed no significant difference in the 
prediction error for 15 out of 17 models, with the exception of the Bagging Multivariate Adaptive 
Regression Splines (BagMARS) and the Neural Network 2 Layer Perceptron (NNet.2MLP). 
Furthermore, analysis of variance showed a significant difference in the error between the 
NNet.2MLP and the rest of the models (p<0.0017) on post hoc analysis. Finally, using a general 
classification tree model, pruning on the error, the different models were separated in 4 groups 
based on the similarity of the residuals for the different samples. Based on these observations, an 
attempt to combine the predictions across the different groups, by averaging the predicted ages for 
the different samples for the best performing model of each group with each other, was made but 
this did not result in any increase in accuracy compared to the best performing individual model 
(SVMp). This result suggests that a considerable proportion of the prediction error in this dataset is 
sample specific rather than depended on the statistics behind the prediction model used, meaning 
that different samples predict with a similar level of accuracy across all models tested. It is possible, 
however, that this is a result of the limited training dataset and a prediction method developed on a 
larger dataset could benefit from the combination of multiple independent statistical approaches 
that would introduce orthogonality into the statistics enabling confidence interval estimations. In this 
case, taking the previous results into account, the SVMp model was chosen for further applications 
of this age prediction method (Fig.5). 
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Figure 5. Comparison between the predicted and the true age for the training (blue, n=76) and blind test set 
(red, n=33) in the SVMp model. The mean absolute prediction error was calculated at 4.0 and 4.1 years 
respectively. 
Sensitivity assessment 
Having optimised this age prediction model and assessed the reproducibility of this analysis at 
standard amounts of DNA input (50ng), for the assay to be forensically relevant it should also be 
applicable to forensically relevant levels of DNA. The next steps of this study were designed to test 
this prediction method in a more realistic set of conditions, starting with a lower DNA input. Two 
methylation standards corresponding to 5% and 25% methylation were analysed starting with an 
initial input (before bisulphite conversion) of 50 (optimum), 25, 10 and 1ng. It is important to note 
that while these amounts correspond to the original DNA quantity used for the analysis, the final 
input in the PCR, following bisulphite conversion (approximately 52% recovery [76]) with elution at 
10µL and use of 2µL for each of the 2 multiplex reactions, was calculated to be approximately 10, 5, 
2 and 0.2ng respectively. The analysis was performed in duplicate and the methylation values 
obtained were compared with the average value for the 50ng input which is the optimum input upon 
which the method was developed (Fig.6). The accuracy in the quantification of DNA methylation was 
retained down to 10ng of initial input (~2ng in the PCR stage) and, while certain markers 
(cg07158339, cg0693994, cg20692569) retained their accuracy down to 1ng of initial input (~200pg 
in the PCR stage), for most markers an increase in the quantification error was observed when 1ng 
was used as starting material. These results correspond with the findings reported by Naue et al. in 
2018, where through simulation experiments the authors suggest that an input in the order of 5ng 
can be used to detect differences in methylation of approximately 10% but higher inputs are required 
in order to achieve resolution any higher than this [87]. AC
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Figure 6. Amount of initial DNA input (ng) and the absolute difference in the quantification of DNA 
methylation form the 50ng input (optimum), for all 12 CpG sites. Two different pre-mixed methylation 
standards were used in this assessment, the first corresponding to 5% (light blue) and the second to 25% 
methylation (dark blue). 
Furthermore, whole blood samples from 6 donors of known age (21.3-79.7 years old) were also 
analysed in duplicate starting with different DNA quantities. The same initial DNA inputs of 50 
(optimum), 25, 10 and 1ng were used and the methylation values obtained were used for the 
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generation of age estimates from the age prediction model. Comparison of the error in age prediction 
(MAE) obtained for the different DNA inputs suggests that, while the accuracy of the predictions is 
retained down to 10ng of original DNA input (~2ng in the PCR stage), the error in age prediction 
increases significantly (p<0.05), at approximately 5-fold, when 1ng is used as starting material (Fig.7). 
These results are a direct match to the results obtained from the previous experiment where the 
accuracy in methylation quantification is shown to be compromised for PCR inputs below ~2ng for 
most markers (Fig.6) and once again correspond with the observations made by Naue et al. in 2018 
[87]. Although a limit of ~2ng is not comparable to that of highly sensitive forensic methods and thus 
further improvement is required for the method to be universally applicable to forensic investigations, 
it still has the best sensitivity reported to this day for DNA methylation based age prediction [30, 43-
47], providing encouraging results for the future of this study. While previous publications have 
reported successful DNA methylation-based age prediction using DNA amounts as low as 10-20ng [43, 
45, 65, 66], this value refers to the PCR input rather than the original DNA amount used for bisulphite 
conversion and thus corresponds to the highest input used in this study. Furthermore, given the fact 
that the proposed method is currently targeted at blood samples rather than contact traces, a higher 
DNA yield is expected. Finally, given the rapid increase observed in both quantification error and 
prediction accuracy between 10 and 1ng this range should be investigated further in the future in 
order to determine the true ‘tipping point’ in the sensitivity.  
 
Figure 7. Amount of initial DNA input (ng) (x axis) and MAE for age prediction for 6 blood samples analysed in 
duplicate. The estimated DNA input (ng) in the PCR stage (post-bisulphite treatment) is also depicted in the 
graph. 
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Application in different tissues 
Finally, while this DNA methylation quantification method and age prediction model were developed 
on whole blood, their applicability to saliva and semen, which together with blood form the three 
most commonly encountered body fluids in forensic investigations, was investigated. A total of 34 
saliva and the sperm fractions of 11 semen samples were analysed with the developed method. The 
reason behind choosing to analyse the sperm fraction instead of the whole semen lies with the 
increased complexity of a tissue consisting of both sperm and epithelial cells as well as the fact that in 
real life cases any potential age prediction assay would be performed following traditional DNA 
analysis which, in the majority of cases involving semen stains, would require differential extraction 
for the isolation of the sperm fraction. Methylation values corresponding to the samples of the two 
tissues where put through the prediction model following normalisation and resulting in a successful 
age prediction for the saliva samples with a mean absolute prediction error of 7.3 years (Fig.8).  The 
relatively low increase in the prediction error in saliva, especially given the fact that this method was 
targeted on whole blood and the prediction model was trained solely on data deriving from whole 
blood samples, suggests that a common model for DNA methylation-based age prediction can be 
developed for both whole blood and saliva. More importantly, these results correspond with previous 
findings suggesting that certain age-correlated DNA methylation markers can be applicable to more 
than one tissues [31, 39-41, 49, 53, 54]. The next step from this would be to re-train a model solely on 
saliva samples while keeping the same marker set. However, this was not possible in this study due to 
the limited number of available samples.  
 
 
Figure 8. Comparison between the predicted and the true age for 34 saliva samples using the age prediction 
model developed in whole blood using Support Vector Machines with polynomial kernel function (SVMp). The 
mean absolute prediction error was calculated at 7.3 years and the root mean square error at 11.1 years. 
On the other hand, in the case of sperm tissue, no methylation (0%) was detected for any marker in 
any of the samples, deeming any attempt to predict chronological age with this marker set 
meaningless. Similar results, with age prediction methods applied successfully to both blood and saliva 
but failing to produce good results in semen, have been previously reported [60] and a possible 
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explanation for these findings could be the methylation reprogramming that is known to occur during 
gamete formation [88]. Even though there are published studies suggesting that DNA methylation in 
semen can be used for age prediction it is not clear if these results represent the sperm or the 
epithelial fraction of the semen, since the analysis is taking place in whole semen samples [56, 60].  
Even when the epithelial fraction is markedly low compared to the sperm fraction in a semen sample, 
large differences in the methylation values between the two could result in a notable difference in the 
DNA methylation quantification values obtained from whole semen when compared with sperm for 
the same sample. It is however, possible that through mechanisms of genetic imprinting, certain 
methylation sites in the gamete DNA would represent the chronological age of the donor and 
therefore could potentially be used in age prediction. 
Conclusions 
The results obtained from this study provide strong evidential support to recent publications 
suggesting that a DNA methylation-based age prediction method can be developed in a way applicable 
to forensic casework. The small amplicon size (<200bp) and the relatively high sensitivity (~10ng of 
initial DNA extracted from a crime scene stain or ~2ng of bisulphite treated DNA) suggest that there 
is potential for such a method to be applied to forensic samples of poor quality and/or low quantity. 
At the same time, the relatively large number of predictors, incorporated in the two multiplex 
reactions described in this method, allows for the inclusion of multiple genomic locations and thus 
enhances the robustness [46] without compromising the sensitivity. Furthermore, this study 
addresses the issue of statistical modelling for methylation analysis of relatively small datasets and 
comes to the same conclusion as Xu et al. [73], suggesting that support vector machines offer a 
potentially more robust, accurate and generalizable modelling approach. With a training/validation 
set consisting of 76 whole blood samples, the developed model was able to successfully predict the 
chronological age of 33 new samples with a mean absolute error (MAE) of 4.1 years and a root mean 
square error (RMSE) of 4.9 years. While the MAE statistic is used throughout this study in order for 
the results to be comparable with relevant publications [30, 43, 45, 46], RMSE was used both to 
compare between the different models tested and to describe the accuracy of the selected model. 
This measure, previously adopted by other studies [30, 31, 46, 49, 60, 65, 89], was selected due to its 
ability to describe both the mean and the spread of the deviation/error within a specific dataset. In 
order to simplify any comparisons this study also reports the median absolute error (3.8 years) and 
the percentage of samples within a certain error ranges (52% of the samples predicting with less than 
4 years of error and 86% with less than 7 years) for the final prediction model, following the layout 
chosen by previous publications [43, 44]. An important note on the reported accuracy of the model is 
that unlike most studies on forensically orientated DNA methylation-based age prediction that focus 
on adults (over the age of 18 years), in this study the dataset also includes younger individuals starting 
at 11 years of age. Removing these samples from the dataset could potentially improve the prediction 
accuracy of the proposed method even further as it has been shown that methylation patterns can 
differ between adulthood and childhood for certain markers [90] most likely due to the high activation 
of the immune system and development during the first years of life [91]. This is the first method, to 
our knowledge, to achieve a combination of age prediction accuracy and sensitivity of this magnitude 
and it provides strong evidence to suggest that a DNA methylation-based age prediction method 
applicable to forensic casework samples can be successfully developed. Furthermore, this prediction 
method was successfully applied to saliva samples with 50% of the samples predicting with less than 
4 years of error and 70% with less than 7 years (MAE=7.3 years, RMSE=11.1 years), suggesting that an 
age estimation method applicable to multiple tissues is a realistic target for forensically orientated 
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DNA methylation-based age prediction methods employing a limited number of predictors. Overall, 
this is the first study of its kind to take a DNA methylation-based age prediction method designed for 
forensic analysis further than the proof-of-concept stage, testing its sensitivity, statistical modelling 
and multi-tissue applicability, all at the same time. However, while this is a step forward towards the 
implementation of this type of analysis in the forensic field, it is only one of many required, with the 
investigation of larger datasets as well as the use of extensive cross-validation being the first ones to 
follow.   
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